Anavex Life Sciences Corp. (AVXL)

5.71
0.02 0.35
NASDAQ
Prev Close 5.73
Open 5.76
Day Low/High 5.72 / 5.89
52 Wk Low/High 2.50 / 14.84
Volume 128.54K
Exchange NASDAQ
Shares Outstanding 41.12B
Market Cap 235.23M
Div & Yield N.A. (N.A)

Latest News

Biotech Stock Mailbag: Sage Therapeutics, Cellceutix, Alzheimer's Risk

Biotech Stock Mailbag: Sage Therapeutics, Cellceutix, Alzheimer's Risk

TheStreet's Adam Feuerstein answers reader questions about biotech stocks.

First Week Of AVXL May 19th Options Trading

First Week Of AVXL May 19th Options Trading

Investors in Anavex Life Sciences Corp saw new options become available this week, for the May 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AVXL options chain for the new May 19th contracts and identified one put and one call contract of particular interest.

Interesting AVXL Put And Call Options For October 20th

Interesting AVXL Put And Call Options For October 20th

Investors in Anavex Life Sciences Corp saw new options begin trading this week, for the October 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Noble Capital Markets Initiates Research Coverage On Anavex Life Sciences Corp. (AVXL)

Noble Capital Markets Initiates Research Coverage On Anavex Life Sciences Corp. (AVXL)

Noble Capital Markets, a leading small-cap focused investment firm, announces the initiation of research coverage of Anavex Life Sciences.

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

Interesting AVXL Put And Call Options For February 2017

Interesting AVXL Put And Call Options For February 2017

Investors in Anavex Life Sciences Corp saw new options begin trading this week, for the February 2017 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AVXL options chain for the new February 2017 contracts and identified one put and one call contract of particular interest.

Biotechs Bolstered on 21st Century Cures Passage

Biotechs Bolstered on 21st Century Cures Passage

Biotechs were trading at high volumes Thursday morning on news that the Senate has passed the 21st Century Cures Act.

Biotech Stock Mailbag: Looking for an Investable Idea in Alzheimer's Minefield

Biotech Stock Mailbag: Looking for an Investable Idea in Alzheimer's Minefield

TheStreet's Adam Feuerstein answers reader questions about biotech stocks.

Gold, Utilities, Bonds Post Gains

I stopped out of Lantheus Holdings for a small loss and bought Baozun near $15.

Anavex Life Sciences Novel Sigma-1 / Sigma-2 Ligand Shows Encouraging Results As An Analgesic In Animal Models Of Neuropathic And Visceral Pain

Anavex Life Sciences Novel Sigma-1 / Sigma-2 Ligand Shows Encouraging Results As An Analgesic In Animal Models Of Neuropathic And Visceral Pain

Preclinical Data for ANAVEX 1066 Presented at Society for Neuroscience Annual Meeting

Short Interest In Anavex Life Sciences Increases 18.6%

Short Interest In Anavex Life Sciences Increases 18.6%

The most recent short interest data has been released for the 10/14/2016 settlement date, which shows a 883,721 share increase in total short interest for Anavex Life Sciences Corp , to 5,641,528, an increase of 18.57% since 09/30/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

5 Stocks Under $10 Poised for Big Breakouts

These under-$10 stocks are within range of triggering breakout trades. Here's how to trade them from here.